Studies on somatic mutations in lung cancers associated with cigarette smoking and asbestos exposure are few. We investigated prevalence of mutations in the p53 and K-ras genes in lung tumors from smokers with and without asbestos exposure at work. For K-ras mutations, the study was an extension of an earlier analysis. Nearly all of the 105 consecutive patients examined were smokers and had non-small-cell carcinoma of the lung with squamous-cell carcinoma or adenocarcinoma histology. Exposure to asbestos was estimated by pulmonary fiber counts and occupational histories. A pulmonary burden of у 1 ϫ 10 6 asbestos fibers per gram of lung tissue, indicating work-related exposure, was found in 32% of the patients for whom fiber-analysis data were available (33 of 102 patients, all men). The statistical analysis showed pulmonary fiber count as the only significant predictor of adenocarcinoma histology, in contrast to squamouscell carcinoma (smoking-adjusted odds ratio [OR] 3.0, 95% confidence interval [CI] 1.1 to 8.5). The frequency of p53 mutations was 39% (13 of 33) among the asbestos-exposed cases, as compared with 54% (29 of 54) among the nonexposed cases; the difference was not significant, however. In male ever-smokers, a long duration of smoking was associated with p53 mutation (OR 3.2, 95% CI 1.2 to 8.8). In adenocarcinoma, p53 mutations were less prevalent (10 of 30, 33%) as compared with squamous-cell carcinoma (28 of 46, 61%; P ϭ 0.02), whereas a strong and significant association was found between adenocarcinoma and K-ras mutation (OR 37, 95% CI 5.8 to 232, adjusted for smoking and asbestos exposure). Asbestos exposure alone was not significantly associated with increased occurrence of K-ras mutations. In conclusion, the results may primarily reflect the observed excess of adenocarcinoma in the asbestosexposed patients, and hence the decrease in p53 mutations and increase in K-ras mutations. 
festation of the disease is observed. The roles of pulmonary fibrosis (asbestosis) and asbestos fibers per se have also been discussed (3, 9) . Finally, the efficacy of asbestos exposure as a complete human carcinogen independent of tobacco smoke has not been entirely settled. Most lung cancers of asbestos-exposed individuals occur in smokers and ex-smokers, and even in large cohort studies the risk estimates for lifetime nonsmokers are based on relatively few lung cancer cases (10) .
Despite many decades of research on asbestos-related pulmonary carcinogenesis, the molecular mechanisms involved have remained largely unknown. Experimental studies have shown that asbestos fibers are genotoxic; they are able to induce DNA damage, chromosome aberrations, mitotic disturbances, and gene mutations (for review, see [11] ). In addition, asbestos fibers can stimulate cell proliferation and chronic inflammation (8, 12) , as well as induce gene expression (13, 14) and malignant transformation of human cells (15) .
Mutations in the p53 tumor suppressor gene are the most common genetic alterations observed in human cancer, and they are particularly frequent in lung cancer (16) . There are several well-known examples of human cancers in which an association between carcinogenic exposure and p53 mutations has been observed, thus supporting involvement of the p53 mutational pathway in carcinogenesis associated with external exposures (16) (17) (18) .
This background prompted us to examine the occurrence of p53 and K-ras mutations in lung tumors from smokers who had been occupationally exposed to asbestos for several years in the past. The mutation data were then analyzed with regard to tumor histology, tobacco smoking, and occupational asbestos exposure. We used tumor cell type, the amount and duration of tobacco smoking, time since quitting smoking, asbestos exposure estimated on the basis of occupational histories, and pulmonary asbestos fiber counts as possible determinants.
Materials and Methods

Lung Cancer Patients
The study population consisted of 105 consecutive lung cancer patients who underwent surgical lobectomy or pulmectomy at the Department of Thoracic and Cardiovascular Surgery at the Helsinki University Hospital (Helsinki, Finland) between August 1988 and October 1992. Most of the patients were smokers. Detailed smoking data were available for 101 patients: 62 (61%) were current smokers; 35 patients (35%) had stopped smoking at least one year before surgery, and 21 of them for five or more years before the operation; four patients (4%) had never smoked. Smoking details were not available for four patients. Eighty-nine men, mean Ϯ SD age of 63 Ϯ 8 yr (range, 35 to 80), and 16 women, mean age of 65 Ϯ 7 yr (range, 43 to 75) were included. Histopathology showed 53 squamouscell carcinomas (47 men and 6 women), 39 adenocarcinomas (30 men and 9 women), five large-cell carcinomas (all men), seven small-cell carcinoma (six men and one woman), and one male adenosquamous carcinoma case. About 65% of the tumors were of stage I-II, and 30% of stage IIIa. Because surgical patients were selected, the proportion of small-cell lung cancers was lower than among lung cancer patients in general. The tumor specimens were also histologically investigated for pulmonary fibrosis (asbestosis) (19) . The study was approved by the ethics committees of Helsinki University Central Hospital and the Finnish Institute of Occupational Health (Helsinki, Finland). A physician experienced in occupational medicine (A. Karjalainen) interviewed all patients in person at the hospital. Each patient gave informed consent before the interview.
Occupational Exposure and Smoking
Complete work history, including past occupational, domestic, and environmental exposure to asbestos, was obtained for each patient at the interview. On the basis of these data, the probability of occupational exposure to asbestos was evaluated by two occupational hygienists by consensus. This was done without any knowledge of the asbestos counts from the tissue samples. An exposure period of 1 mo was regarded as a minimum. Each patient was classified into one of the four exposure categories (definite, probable, possible, unlikely), as described (20) . In addition, the frequency and duration of the tasks with at least probable exposure to asbestos were also considered in the classification. The personal interview also included questions on the patient's smoking history: Age at starting and quitting smoking, nonsmoking periods longer than 6 mo, and the daily consumption of cigarettes/cigars/pipes were recorded. Only three patients had used tobacco products other than cigarettes (pipe).
Lung Tissue Samples and Fiber Analysis
The tissue pieces for electron microscopic fiber analysis were taken from the peripheral part of the lung and did not include pleural or tumor tissue. In case of bilobectomy or pulmectomy, the sample was taken from the lobe that appeared to be closest to normal. Organic tissue was removed from a tissue piece of about 100 mg wet weight by low-temperature ashing. Fibers were detected with a JEOL 100 CX-ASID4D electron microscope (JEOL Ltd., Tokyo, Japan) in scanning electron microscopy (SEM) mode at 5,000-fold magnification. A length-to-width ratio greater than 3 and roughly parallel sides were used as criteria for fiber. Fibers longer than 1 m could be detected. At minimum, 200 viewing fields were evaluated to find at least four to 30 fibers per sample, depending on the density. An analytical sensitivity (one fiber per sample) of about 0.1 ϫ 10 6 fibers per gram (f/g) dry tissue could be reached. An energy-dispersive X-ray microanalyzer (Tracor TN 5500; Noran Instruments, Middleton, WI) was used to determine the fiber type by comparing peak ratios with standard spectra. The total pulmonary concentration of asbestos fibers was used as an indicator of past asbestos exposure. Chrysotile fibers are poorly detected with SEM and, consequently, the results represent the concentration of amphibole fibers. On the basis of previous studies, a concentration exceeding 1.0 ϫ 10 6 f/g was considered highly indicative of past occupational exposure to asbestos (21) .
Tissue Samples and Analysis of p53 and K-ras Genes
Representative samples of fresh tumor tissue were provided by the pathologist and frozen at Ϫ 80 Њ C for future mutation analysis. DNA was extracted from the tissue sample by phenol-chloroform extraction as described elsewhere (22) . All lung tumor samples were screened for p53 alterations using denaturant gradient gel electrophoresis (DGGE). Polymerase chain reaction (PCR)-DGGE of exons 5-9 as well as the procedures and sequencing primers for direct sequencing were the same as given previously (22) (23) (24) . At minimum, two to three separate PCR products from each sample were sequenced to confirm the result. Activating point mutations in the K-ras gene exons 1 and 2 (codons 12, 13, 61) were examined from the same tissue samples as p53 gene mutations; the methods and details have been given elsewhere (25, 26) . Altogether, 97 lung tumors were studied for K-ras mutations; the present study is an extension of a previously published analysis (26) .
Statistical Analysis
Bivariate and multivariate logistic regression models were applied in quantifying the associations between end-point parameters (lung cancer cell type, and p53 or K-ras mutations) and indicators of previous exposure to asbestos and to tobacco smoke. Past exposure to asbestos was analyzed using pulmonary fiber burden ( Ͻ 1.0 ϫ 10 6 f/g versus у 1.0 ϫ 10 6 f/g) as the criterion for occupational exposure. Because none of the female patients had been exposed to asbestos at work, only men were included in the analyses. All P values given are one-sided.
Results
Asbestos Exposure of the Patients
Demographic and background data for cigarette smoking and asbestos exposure of the patients are presented in Table 1. Thirty-three patients (32%, all men) out of the 102 for whom fiber-analysis data were available showed a pulmonary deposition of 1 million or more amphibole asbestos fibers per gram of dry lung tissue (range 1.0 to 145 ϫ 10 6 f/g); this is considered highly indicative of occupational exposure to asbestos. Antophyllite was the main type of asbestos fiber detected. Job history data on these patients indicated work-related exposure in the past: 30 of the 33 patients with a history of asbestos exposure were classified as definitely, probably, or possibly exposed. Of these, seven patients were diagnosed with asbestosis. For 69 patients, the pulmonary fiber concentration was below 1 million (range Ͻ 0.3 to 0.95 ϫ 10 6 f/g; Table 1 ).
Tumor Histology
Of the cases not exposed to asbestos, 59% were squamous-cell carcinomas and 26% adenocarcinomas. For the exposed cases, the corresponding prevalences were 42% and 48%, respectively; that is, the frequency of adenocarcinoma was almost twofold (Figure 1 p53 Mutations In all, 51% (54 of 105) of the patients exhibited a somatic p53 mutation. The mutation analysis showed that 39% (13 of 33) of the occupationally exposed male cases had a p53 mutation, as compared with 54% (29 of 54) of the nonexposed male cases. The prevalence of mutations tended to decrease with the increasing amounts of fibers in the lungs, being only 20% (2 of 10) among the cases with the highest pulmonary asbestos-fiber content ( у 5 ϫ 10 6 f/g) ( Figure  1) . The difference remained, however, statistically nonsignificant (Table 3) . Of the exposed cases with histologic as- Figure 1 . Prevalence of adenocarcinoma histology (%), p53 mutations, and K-ras mutations in male lung cancer patients with (pulmonary asbestos fiber concentrations 1 to Ͻ 5 ϫ 10 6 and у 5 ϫ 10 6 f/g dry weight) and without (Ͻ 1 ϫ 10 6 f/g) occupational exposure to asbestos. bestosis, two (2 of 7, 29%) had a p53 mutation. Interestingly, mutations in p53 gene were significantly less prevalent in adenocarcinoma (10 of 30, 33%), the cell type associated here with asbestos exposure, as compared with squamous-cell carcinoma (28 of 46, 61%; P ϭ 0.02).
The locations and types of mutations detected in the asbestos-exposed cases are presented in Table 4 . The mutations seen were primarily missense and nonsense mutations; one deletion causing a frameshift had also occurred. Exon 5 was the most frequently mutated region (5 of 13, 38%), with two identical G-to-C transversions at codon 181. In all, among the exposed, six base substitutions had occurred at G:C base pairs (6 of 12, 50%), including two G:C-to-T:A transversions (17%) and one G:C-to-A:T transition at a non-CpG site. In addition, three (3 of 12; 25%) A:T-to-G:C transitions were detected; altogether five base substitutions had occurred at A:T pairs (5 of 12, 42%) ( Table 4) .
The nonexposed smokers carried 39 mutations, 32 of which were identified by sequencing. This group showed 10 (31%) G-to-T transversions on the nontranscribed strand, a mutation characteristic to tobacco-smoke exposure. In smokers, the most frequently mutated codons were as follows: codons 155 and 173 had mutated twice, codon 245 three times, and codon 273 twice. Of these, codons 245 and 273 are included in the hot-spot mutational sites of lung cancer. In addition, hot-spot codons 157, 158, 179, 248, and 282 were all mutated once. Thus, the lung cancer-associated hot-spot codons harbored 31% (10 of 32) of the mutations observed in nonexposed smokers as compared with one (8%) in the asbestos-exposed cases.
One feature of the study population was that one-third of the asbestos-exposed cases were long-term ex-smokers. Among male cases, the highest rate of mutations (53%) was observed among current smokers without occupational exposure, and the rate was somewhat lower among the men who had quit smoking у 5 yr before the operation ( Table 5 ). The statistical analysis revealed long duration of smoking as a statistically significant predictor of p53 mutation (Table 3) .
K-ras Mutations
The frequency of patients with K-ras mutations was 21% (20 of 97). In men, adenocarcinoma histology showed strong and significant association with K-ras mutation (OR 37, 95% CI 5.8 to 232; Table 6 ). Mutation frequency Includes ever-smoker men, adenocarcinoma, and squamous-cell carcinoma histologies only. All predictors are included in the multivariate models. Excludes subjects with missing data in any variable in the analysis.
Predictor, exposed category given in parentheses. NEC, number of exposed cases. See footnotes to Table 2 .
was 33% (10 of 30) in cases with occupational asbestos exposure, and 17% (9 of 54) in the nonexposed cases (P ϭ 0.07). The frequency seen in the exposed cases with histologic asbestosis was 29% (2 of 7). The distribution of K-ras mutations according to pulmonary asbestos-fiber content is shown in Figure 1 . The univariate analysis suggested an increased probability of K-ras mutations in the occupationally exposed cases, but the OR came close to unity in the multivariate analysis ( Table 6 ). The K-ras mutation frequency roughly followed the daily amount of cigarettes smoked; this was seen particularly in men. The prevalence of K-ras-positive male cases was 13% (2 of 16) in smokers who smoked Ͻ 20 cigarettes/d, 21% (6 of 29) in those smoking 20 to 29 cigarettes/d, and 36% (5 of 14) in those who consumed у 30 cigarettes/d. The differences were suggestive, but not statistically significant (P for trend, 0.07).
Discussion
In this work, 105 lung cancer patients (mainly men with non-small-cell lung cancer of stage I-IIIa) who were consecutively admitted to hospital for a curative operation were examined for the presence of mutations in the p53 tumor suppressor gene and K-ras oncogene. Of the cases studied, 33 had been exposed to asbestos at work, based on pulmonary asbestos-fiber counts determined by SEM and in-person interviews. The results indicated that lung tumors with p53 mutation were not more common among the cases with occupational asbestos exposure (39%) than in the nonexposed cases (54%). The group with the heaviest occupational exposure appeared to have a lower prevalence of p53 mutations (20%) than the patients with lower fiber counts (48%). The results suggested a negative correlation between pulmonary fiber burden and p53 mutation frequency, but the OR remained nonsignificant in the multivariate analysis.
In previous studies, an association between p53 protein overexpression or mutations and asbestos exposure has been suggested (27) (28) (29) (30) . The published studies deviate from the present one in some respects. First, in contrast to the other studies, we used the concentration of asbestos fibers measured in the lung tissue for documentation of the occupational exposure. In addition, work history was used for probability and timing of the exposure. Second, the earlier studies examined relatively few exposed cases, whereas we studied cases from an industrial area with onethird of our lung cancer population occupationally exposed to asbestos. In agreement with the present findings, preliminary results from a study that used asbestos body measurements and questionnaire-based exposure classification as the exposure indicators did not find accumulation of p53 protein among the exposed lung cancer cases (31) . Previously, lung cancers from subjects with asbestosinduced fibrosis, indicating heavy asbestos exposure, did not show increased p53 mutation frequency or protein expression (24) . Experimental animal studies have also shown conflicting results. Expression of p53 was induced in the lungs of chrysotile asbestos-treated rats but not in Long-term ex-smoker, у 5 yr since cessation.
the control rats exposed to iron beads (32) . Another study reported lack of p53 mutations in crocidolite-induced tumors, whereas treatment with benzo(a)pyrene resulted in tumors with p53 mutations (33) . The types of base substitutions observed here in the exposed versus nonexposed cases had different features. In the exposed group, half of the mutations resided at G:C pairs, but only two (17%) were G:C-to-T:A transversions on the nontranscribed strand. In contrast, 30% of the mutations observed in the nonexposed cases were G-to-T transversions, a frequency comparable with findings from other studies and the p53 mutation database (16, 34) . G:Cto-T:A is a base substitution typically seen in lung cancer, and is indicated as a hallmark of exposure to tobacco smoke (16) and to benzo(a)pyrene in particular (35) . Another source for base modifications at G:C pairs in both groups may be oxygen free radicals. Exposure to tobacco smoke and asbestos fibers both result in generation of oxidative damage (36, 37) , especially in formation of 8-OHdeoxyguanosine (38, 39) , which in turn causes primarily G-to-T transversions, but other substitutions are detected as well (40, 41) . Here the small frequency of G-to-T transversions detected in the asbestos-exposed cases did not speak in favor of enhancement of this mechanism in association with co-exposure. Previously, a predominance of G-to-T transversions in asbestos-exposed lung cancers has been reported (28, 29) , but not in all studies (30) . G:C-to-A:T transitions were rare (1 of 12, 8%) in the present exposed cases, but represented the second most frequent type of mutation in the nonexposed smokers (totally, 8 of 33, 24%; at non-CpG, 6 of 8). This is in keeping with the hypothesis and previous data that G:C-to-A:T transitions in cancers associated with external exposure characteristically occur at non-CpG sites (16) . Finally, because asbestos fibers induce DNA strand breaks (11) , deletions may be expected as typical mutation. However, only one deletion was seen in the exposed lung cancers.
Reasons for the observed lower occurrence of p53 mutations among the asbestos-exposed male lung cancers compared with the nonexposed smoking ones may be multiple. At cellular level, not only tobacco smoke constituents but also asbestos fibers induce DNA damage (11) and apoptosis (42, 43) , both important factors in carcinogenesis and tumor formation. Because p53 controls cell growth and division by being a sensor of DNA damage and a mediator of apoptosis (44) , one would expect that cellular pathways leading to loss of p53 function due to mutations would be prominent in smoking-and asbestos-related carcinogenesis. Asbestos fibers can nevertheless affect regulation of transcription and gene expression via many other cellular mediators (8, 13, 14, (45) (46) (47) , an observation that may suggest a less significant role for selection for somatic p53 mutations. In agreement with this, p53 mutations have infrequently been seen in human malignant mesothelioma, a pulmonary malignancy related to asbestos exposure (48, 49) .
In adenocarcinoma, a strong and significant association between this cell type and K-ras mutation was observed, whereas p53 mutations were less frequent in comparison with squamous-cell carcinoma. The relationship between adenocarcinoma and K-ras mutations has been reported previously (50, 51) , with the suggestion that mutations may occur in adenocarcinoma frequently enough to be used as a molecular marker in clinical work (52) . The frequency of K-ras mutations showed an increasing trend with increasing daily smoking, and mutations were more frequent in the exposed than in the nonexposed cases, as was the case in a subset of the present study population (26) . After adjustment for smoking and histology, the association between K-ras mutations and asbestos exposure remained, however, nonsignificant.
With regard to lung cancer histology and exposure to asbestos, the study showed a significant association between high pulmonary asbestos-fiber content and adenocarcinoma histology. A preponderance of adenocarcinomas has been observed among asbestos-exposed lung cancer patients in some but not all previous studies (53) (54) (55) (56) (57) . Recently, a large, cancer registry-based follow-up of 1,300 men with asbestosis and 4,700 men with benign asbestos-related pleural disease was carried out (58) . The results indicated a clearly increased risk for all main histologic types of lung cancer in male patients with asbestosis. The risk estimates were, however, somewhat higher for adenocarcinoma and small-cell carcinoma than for squa- mous-cell carcinoma in both groups (58) . Selection of patients and diagnostic procedure (surgery, bronchoscopy, autopsy), as well as variation in the mean intensity of asbestos exposure, may influence the results obtained from the various studies. For example, none of the female patients in our study had been occupationally exposed to asbestos. Our analyses were therefore restricted to men only. Also, because the study comprised surgical cases of lung cancer, only two histologic types of non-small-cell lung cancer (adenocarcinoma and squamous-cell carcinoma) were taken into account. Consequently, no direct conclusions can be drawn from the present results on female lung cancer or small-cell lung cancer.
In conclusion, we propose that the observed differences in the frequencies of p53 and K-ras mutations between the asbestos-exposed and nonexposed lung cancer cases may, at least partially, reflect the relative increase of adenocarcinoma cell type among the exposed cases.
